AMITIZA 8 MCG CAPSULE

lubiprostone
$6.4677per EA
High Outlier

Strength

8 ug/1

Manufacturer

SpecGx LLC

NDC

23635050860

Classification

Brand

Dosage Form

CAPSULE, GELATIN COATED

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

LUBIPROSTONE

Approval Type

New Drug (NDA)

FDA Application

NDA021908

On Market Since

4/1/2024

Pharmacological Classes

Chloride Channel Activator
Chloride Channel Activators

Price History

1W

0.0%

1M

+0.1%

3M

+0.3%

6M

+0.3%

1Y

+0.4%

3Y

N/A

5Y

N/A

All

+1.1%

Related Drugs

Same classification

No related drugs found.